Barr Foresees Plan B Launch In The Fall Under “Best” Circumstances
This article was originally published in The Pink Sheet Daily
Executive Summary
The company expects that labeling discussions will last three to four months following an “approvable” decision by the May 21 user fee date. Barr’s promotional efforts will focus on educating health care providers.
You may also be interested in...
Plan B OTC Submission Deemed "Not Approvable"
Barr will have to detail a mechanism for drugstores to screen women less than 16 years of age for nonprescription use of the emergency contraceptive. FDA's decision goes against the recommendation of its advisory panels.
Savient Delays 10-Q Filing Due To Oxandrin Return Reserve Errors
The firm will restate first quarter and 2004 year-end results due to less-than-expected returns of the anabolic agent.